Peter R Corridon1,2,3, In Kap Ko1, James J Yoo1, Anthony Atala1. 1. Wake Forest Institute for Regenerative Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA. 2. Department of Physiology & Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 3. Department of Craniofacial Biology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Abstract
PURPOSE OF REVIEW: Historically, there have been many advances in the ways in which we treat kidney diseases. In particular, hemodialysis has set the standard for treatment since the early 1960s and continues today as the most common form of treatment for acute, chronic, and end-stage conditions. However, the rising global prevalence of kidney diseases and our limited understanding of their etiologies have placed significant burdens on current clinical management regimens. This has resulted in a desperate need to improve the ways in which we treat the underlying and ensuing causes of kidney diseases for those who are unable to receive transplants. RECENT FINDINGS: One way of possibly addressing these issues is through the use of improved bioartificial kidneys. Bioartificial kidneys provide an extension to conventional artificial kidneys and dialysis systems, by incorporating aspects of living cellular and tissue function, in an attempt to better mimic normal kidneys. Recent advancements in genomic, cellular, and tissue engineering technologies are facilitating the improved design of these systems. SUMMARY: In this review, we outline various research efforts that have focused on the development of regenerated organs, implantable constructs, and whole bioengineered kidneys, as well as the transitions from conventional dialysis to these novel alternatives. As a result, we envision that these pioneering efforts can one day produce bioartificial renal technologies that can either perform or reintroduce essential function, and thus provide practical options to treat and potentially prevent kidney diseases.
PURPOSE OF REVIEW: Historically, there have been many advances in the ways in which we treat kidney diseases. In particular, hemodialysis has set the standard for treatment since the early 1960s and continues today as the most common form of treatment for acute, chronic, and end-stage conditions. However, the rising global prevalence of kidney diseases and our limited understanding of their etiologies have placed significant burdens on current clinical management regimens. This has resulted in a desperate need to improve the ways in which we treat the underlying and ensuing causes of kidney diseases for those who are unable to receive transplants. RECENT FINDINGS: One way of possibly addressing these issues is through the use of improved bioartificial kidneys. Bioartificial kidneys provide an extension to conventional artificial kidneys and dialysis systems, by incorporating aspects of living cellular and tissue function, in an attempt to better mimic normal kidneys. Recent advancements in genomic, cellular, and tissue engineering technologies are facilitating the improved design of these systems. SUMMARY: In this review, we outline various research efforts that have focused on the development of regenerated organs, implantable constructs, and whole bioengineered kidneys, as well as the transitions from conventional dialysis to these novel alternatives. As a result, we envision that these pioneering efforts can one day produce bioartificial renal technologies that can either perform or reintroduce essential function, and thus provide practical options to treat and potentially prevent kidney diseases.
Entities:
Keywords:
Bioengineering; Bioratificial kidney; Cell therapy and gene therapy; Dialysis; Regenerative medicine
Authors: Jennifer L Huang; Adrian S Woolf; Maria Kolatsi-Joannou; Peter Baluk; Richard N Sandford; Dorien J M Peters; Donald M McDonald; Karen L Price; Paul J D Winyard; David A Long Journal: J Am Soc Nephrol Date: 2015-06-02 Impact factor: 10.121
Authors: Farah Tasnim; Rensheng Deng; Min Hu; Sean Liour; Yao Li; Ming Ni; Jackie Y Ying; Daniele Zink Journal: Fibrogenesis Tissue Repair Date: 2010-08-10
Authors: Ning Cai; Alvin Chi-Keung Lai; Kin Liao; Peter R Corridon; David J Graves; Vincent Chan Journal: Polymers (Basel) Date: 2022-05-07 Impact factor: 4.967
Authors: Rafael Soares Lindoso; Fjodor A Yousef Yengej; Franziska Voellmy; Maarten Altelaar; Estela Mancheño Juncosa; Theano Tsikari; Carola M E Ammerlaan; Bas W M Van Balkom; Maarten B Rookmaaker; Marianne C Verhaar; Rosalinde Masereeuw Journal: J Nanobiotechnology Date: 2022-07-15 Impact factor: 9.429